Central mechanisms and levodopa response fluctuations in Parkinson's disease.
Mouradian
M M
MM
Experimental Therapeutics Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland 20892.
Chase
T N
TN
D006801:Humans; D007980:Levodopa / Q000493:pharmacokinetics* / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy / Q000503:physiopathology*
D007980:Levodopa